We use artificial intelligence and computational chemistry to accelerate drug discovery and design. Deep learning, molecular simulation, and large-scale data analysis help move promising ideas toward validated candidates.

We build reusable drug-design workflows around Pre-clinical drug discovery,including target identification, hit-finding, hit-to-lead, molecular representation, virtual screening, and experimental validation.
Leverage deep learning and machine learning to accelerate drug candidate screening and optimization, improving efficiency and accuracy.
Understand drug-target interaction mechanisms through molecular simulation and quantum chemistry calculations.
Integrate modeling and simulations to comprehensively construct structure-function frameworks for target systems.
Combine computational and experimental approaches to design and optimize lead compounds with high activity and favorable pharmacokinetic properties.
Precisely screen and design targeted therapeutics based on target structure and functional characteristics.
Leverage deep learning and machine learning to accelerate drug candidate screening and optimization, improving efficiency and accuracy.
Understand drug-target interaction mechanisms through molecular simulation and quantum chemistry calculations.
Integrate modeling and simulations to comprehensively construct structure-function frameworks for target systems.
Combine computational and experimental approaches to design and optimize lead compounds with high activity and favorable pharmacokinetic properties.
Precisely screen and design targeted therapeutics based on target structure and functional characteristics.
An interdisciplinary team across artificial intelligence, medicinal chemistry, computational chemistry, computational biology, and platform engineering.

Professor, PI
Department of Pharmaceutical Science
School of Medicine, Shanghai University
yuemin@shu.edu.cn+86 15261860117



